DEERFIELD, Ill.--(BUSINESS WIRE)--
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announces a binding
offer from Fareva for a 10-year global agreement for the manufacture and
supply of own beauty brands and private label products, including
products for sale in the USA. The proposed agreement will create a
partnership to provide Walgreens Boots Alliance with a core
multinational manufacturing and development resource, enabling the
company to accelerate its global product strategy.
Under the terms of the offer, Fareva will take ownership of BCM,
Walgreens Boots Alliance's contract manufacturing business, which
operates factories in the UK, France and Germany.
Fareva manufactures in 11 countries, including the USA, and has
significant research and development capabilities.
The proposed agreement, which is subject to Works Council consultation
and regulatory approval, is expected to be completed by the end of
calendar year 2017.
Notes to Editors:
About Walgreens Boots Alliance
Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led,
health and wellbeing enterprise.
The company was created through the combination of Walgreens and
Alliance Boots in December 2014, bringing together two leading companies
with iconic brands, complementary geographic footprints, shared values
and a heritage of trusted health care services through pharmaceutical
wholesaling and community pharmacy care, dating back more than 100 years.
Walgreens Boots Alliance is the largest retail pharmacy, health and
daily living destination across the USA and Europe. Walgreens Boots
Alliance and the companies in which it has equity method investments
together have a presence in more than 25* countries and employ more than
400,000* people. The company is a global leader in pharmacy-led, health
and wellbeing retail and, together with the companies in which it has
equity method investments, has over 13,200* stores in 11* countries as
well as one of the largest global pharmaceutical wholesale and
distribution networks, with over 390* distribution centers delivering to
more than 230,000** pharmacies, doctors, health centers and hospitals
each year in more than 20* countries. In addition, Walgreens Boots
Alliance is one of the world's largest purchasers of prescription drugs
and many other health and wellbeing products.
The company's portfolio of retail and business brands includes
Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as
increasingly global health and beauty product brands such as No7,
Botanics, Liz Earle and Soap & Glory.
In October 2016 Walgreens Boots Alliance received the United Nations
Foundation Global Leadership Award for its commitment to the UN's
Sustainable Development Goals. The company also ranks No. 1 in the Food
and Drug Stores industry of Fortune magazine's 2017 list of the World's
Most Admired Companies.
More company information is available at www.walgreensbootsalliance.com.
* As of 31 August 2016, using publicly available information for
** For 12 months ending 31 August 2016, using publicly available
information for AmerisourceBergen.
Cautionary Note Regarding Forward-Looking Statements
All statements in this release that are not historical including,
without limitation, those regarding the offer from Fareva for a 10-year
global agreement, including the terms, timing, consummation and effects
thereof, and any estimates of future financial and operating
performance, are forward-looking statements made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of
1995. Words such as "expect," "pending," "potential", "likely,"
"preliminary," "would," "could," "should," "can," "will," "project,"
"intend," "plan," "goal," "continue," "synergy," "on track," "believe,"
"seek," "estimate," "anticipate," "may," "possible," "assume," and
variations of such words and similar expressions are intended to
identify such forward-looking statements. These forward-looking
statements are not guarantees of future performance and involve risks,
assumptions and uncertainties, including those associated with the
terms, timing, consummation and effects of such proposed long term
global supply agreement with Fareva, including the risk that the
agreement may not be completed due to one or more closing conditions not
being satisfied or waived, risks related to the ability to realize the
anticipated benefits of the proposed agreement, outcome of legal and
regulatory matters, the occurrence of any event, change or other
circumstance that could give rise to the termination, cross-termination
or modification of any of our contractual obligations, the amount of
costs, fees, expenses and charges incurred in connection with strategic
transactions, changes in management's assumptions, the risks associated
with governance and control matters, changes in market and regulatory
conditions, and those described in Item 1A (Risk Factors) of our Form
10-K for the fiscal year ending 31 August 2016 and our Form 10-Q for the
fiscal quarter ended 31 May 2017, each of which is incorporated herein
by reference, and in other documents that we file or furnish with the
Securities and Exchange Commission. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially. These forward-looking
statements speak only as of the date they are made. Except to the extent
required by law, we do not undertake, and expressly disclaim, any duty
or obligation to update publicly any forward-looking statement after the
date of this release, whether as a result of new information, future
events, changes in assumptions or otherwise.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170725005654/en/
Walgreens Boots Alliance
USA / Michael
+1 847 315 2935
International / Laura Vergani
(0)207 980 8585
Gradwell and Ashish Kohli
+1 847 315 2922
Source: Walgreens Boots Alliance
News Provided by Acquire Media